BioMark logo

BioMark

Asia, Central Region, Singapore, Singapore

Description

On a mission to get the world biomarking - a global preventative healthcare movement.

Investor Profile

BioMark has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Malaysia.
  • Strong thematic focus on Artificial Intelligence (AI), Health Care, InsurTech.

Stage Focus

  • Series A (100%)

Country Focus

  • Malaysia (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Health Care
  • Insurtech
  • Mental Health
  • Mhealth
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioMark frequently co-invest with?

Integra Partners
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Palm Drive Capital
North America, New York, United States, New York
Co-Investments: 1
INP Capital
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
HF
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Co-Investments: 1
M Venture Partners (MVP)
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Sumitomo Corporation Equity Asia
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Duopharma Biotech
Asia, Selangor, Malaysia, Selangor
Co-Investments: 1

What are some of recent deals done by BioMark?

Naluri Life

Kuala Lumpur, Kuala Lumpur, Malaysia

Naluri is a digital health solution platform that predicts, prevents, and manages cardiometabolic and mental health conditions.

Artificial Intelligence (AI)Health CareInsurTechMental HealthmHealthTherapeutics
Series AJun 9, 2021
Amount Raised: $5,000,000